# Tiotropium

## Spiriva Respimat 2.5mcg/puff

##### 

| Title              | Content                                                                                                                                                                                                                                                                                         |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ESPIR                                                                                                                                                                                                                                                                                           |
| Indications        | Maintenance treatment of patients with COPD (including chronic bronchitis & emphysema).                                                                                                                                                                                                         |
| Dosing             | Adult:Inhale 2 puffs once daily at the same time of day. Age 6-17 years with asthma: 2 puffs once daily at the same time of day. Age <6 years: Limited data available.                                                                                                                          |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                   |
| Contraindications  | Patients with a history of hypersensitivity to atropine or its derivatives eg， ipratropium or oxitropium， or to any component of Spiriva.                                                                                                                                                     |
| Adverse Effects    | GI disturbances， cough & local irritation， dysuria， urinary retention (in men)， tachycardia， allergic reactions. Gastrointestinal: Constipation (4% )， Xerostomia (12% to 16% ) Respiratory: Pharyngitis (7% to 9% )， Sinusitis (3% to 11% )， Upper respiratory infection (41% to 43% ) |
| Pregnancy          | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                   |

